Åslaug Helland

22PUBLICATIONS
79CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 08, 2026
Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.

|Mar 19, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Frigg Å Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll

|Mar 04, 2026
Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025.

Elisa Bjørgo, Nina Ånensen, Gro Live Fagereng

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Jan 07, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

|Mar 15, 2024
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Anastasia Brativnyk, Jørgen Ankill, Åslaug Helland

Pageof 4

Frequent Collaborators

4 joint publications

Kjetil Taskén

2 joint publications

Bjørn Henning Grønberg

2 joint publications

Vilde Drageset Haakensen

2 joint publications

Henrik Horndalsveen